Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Daiichi Sankyo

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

QUIZARTINIB DIHYDROCHLORIDE

Brand Name : VANFLYTA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 17.7MG BASE

Packaging :

Approval Date : 2023-07-20

Application Number : 216993

Regulatory Info : RX

Registration Country : USA

blank

02

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

QUIZARTINIB DIHYDROCHLORIDE

Brand Name : VANFLYTA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 26.5MG BASE

Packaging :

Approval Date : 2023-07-20

Application Number : 216993

Regulatory Info : RX

Registration Country : USA

blank